Sonoma Pharmaceuticals (SNOA) Return on Sales (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Return on Sales of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and up 44.52% quarter-over-quarter from 0.0% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Return on Sales (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Return on Sales history runs 17 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2026 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q3 2025, with the low at 0.01% in Q4 2022.
- The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.0%.
- Peak annual rise in Return on Sales reached 0 bps in 2022, while the deepest fall reached 1 bps in 2022.
- Sonoma Pharmaceuticals' Return on Sales stood at 0.01% in 2022, then jumped by 58 bps to 0.0% in 2023, then grew by 6 bps to 0.0% in 2024, then increased by 28 bps to 0.0% in 2025, then surged by 45 bps to 0.0% in 2026.
- Business Quant data shows SNOA's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.47 Bn | 43.51 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.56 Bn | 39.90 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 32.32 Bn | 30.65 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.07 Bn | 19.41 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.96 Bn | 18.07 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.46 Bn | 15.07 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |